Affinity Asset Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300,000
Closed -$4.19M 105
2023
Q4
$4.19M Buy
300,000
+100,000
+50% +$1.39M 0.77% 36
2023
Q3
$2.95M Buy
+200,000
New +$2.81M 0.83% 37

Other funds holding DVAX

Affinity Asset Advisors's DVAX Position: Q1 2024 in Review

Affinity Asset Advisors sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 300,000 shares — an estimated $4.19M sold.

Affinity Asset Advisors first reported a position in DVAX in Q3 2023 and held it in 2 quarters. The position peaked at $4.19M in Q4 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Affinity Asset Advisors reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 300,000 Dynavax Technologies shares in Q1 2024, an estimated $4.19M.
  • Affinity Asset Advisors first reported a position in Dynavax Technologies in Q3 2023 and held it in 2 quarters.
  • Affinity Asset Advisors's Dynavax Technologies position peaked at $4.19M in Q4 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Affinity Asset Advisors's 13F filing for Q1 2024, filed 14 May 2024.